Here's a breakdown of what the study found, how the protocol worked, and why this data matters
Its activity intersects two major metabolic pathways simultaneously: the NAD+ biosynthesis pathway (by consuming nicotinamide, an NAD+ precursor, NNMT competes with the NAD+ salvage pathway) and the methyl-donor pathway (by consuming SAM, NNMT reduces the availability of methyl groups for epigenetic and metabolic methylation reactions)
Rev Med Interne 2009;30 Suppl
They are not drugs and are not intended for human administration
Research Diluent Solution 10mL $15.00 Add to cart MOTS-C 10mg $54.00 Add to cart BPC-157 10mg $44.00 Add to cart Tesamorelin 10mg $68.00 Add to cart GHK-Cu Lyophilized 50mg $35.00 Add to cart CJC-no DAC / Ipamorelin Blend 5mg/5mg $53.00 Add to cart EZP-3P 12mg $82.00 Add to cart Research Diluent Solution 30mL $35.00 Add to cart Klow Blend 80mg $98.00 Add to cart Buffered NAD+ 500mg $68.00 Add to cart EZP-2P 30mg $98.00 Add to cart EZP-3P 24mg $118.00 Add to cart KPV 10mg $44.00 Add to cart Glow Blend (BPC-157/TB4/GHK-Cu) 70mg $88.00 Add to cart GHK-cu Lyophilized 100mg $53.00 Add to cart Why Researchers Trust EZ Peptides US-based, independently verified, and focused on consistent results with every order
GLP-1 Medications: The Metabolic Component GLP-1 receptor agonists (semaglutide, tirzepatide, liraglutide) are the metabolic backbone of this stack
